Skip to content

Relizema cream

by RELIFE S.r.l. 3 variants

Ref ZV0362, ZV0361, ZS0345, ZS0347Model DLP011

Active European Union

CE MDR

Valid until

10 Jul 2030

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier KIWA CERMET ITALIA S.P.A.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberMDR 00138-A Date12 Jan 2026IssuedStatusActive expires 10 Jul 2030

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • MDR 00138-A Active

    Quality management system EU MDR

    Certifier
    KIWA CERMET ITALIA S.P.A. 0476
    Issued
    12 Jan 2026
    Expires
    10 Jul 2030

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Model / Reference
DLP011, ZV0362, ZV0361, ZS0345, ZS0347
Primary DI / UDI-DI
08055348240016, 08055348240023, 08055348240030, 08055348240061
Basic UDI-DI
805534824RelizemaCreamJ9
EMDN Code
M9002 Protective devices, lubricants and soothing devices (sprays, gels, fluids and creams)
Device Class
Class IIa
EU market of registration
Ireland

Manufacturer details

EUDAMED SRN
IT-MF-000007611

Other devices from RELIFE S.r.l.

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No